MetaCap

Who Owns Solid Biosciences Stock?

NASDAQ: SLDBHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

6.25-0.19 (-2.95%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Ownership breakdown

Held by institutions
106.08%
Institutional holders
214
  • Institutions 99.3%
  • Insiders 0.7%
  • Public and other 0.0%

Who owns Solid Biosciences stock?

Institutional investors own about 106.1% of Solid Biosciences's shares, spread across 214 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 0.66% of SLDB.

The largest institutional holders are RA Capital Management, L.P. (10.78%), Perceptive Advisors Llc (10.67%) and Bain Capital Life Sciences Investors, LLC (8.79%). Together, the top 10 institutions control 66.4% of shares outstanding. In their latest filings, 4 of the top 10 institutions increased their SLDB positions and 2 reduced them.

Summary generated from market data by MetaCap's automated system. Methodology

Top institutional holders of SLDB

Solid Biosciences top institutional holders
InstitutionShares% HeldChange
RA Capital Management, L.P.12.04M10.78%0.0%
Perceptive Advisors Llc11.91M10.67%0.0%
Bain Capital Life Sciences Investors, LLC9.81M8.79%0.0%
Siren, L.L.C.7.69M6.89%0.0%
FMR, LLC7.27M6.52%+5.8%
Blackrock Inc.6.84M6.12%-1.4%
RTW Investments LP5.91M5.29%+51.7%
Armistice Capital, LLC4.50M4.03%+5.1%
Franklin Templeton, Inc.4.19M3.76%+21.9%
Vanguard Capital Management LLC3.97M3.56%-1.1%

% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.

Top mutual fund and ETF holders of SLDB

Solid Biosciences top fund holders
FundShares% Held
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund3.15M2.82%
Fidelity Select Portfolios-Select Biotechnology Portfolio2.61M2.34%
iShares Trust-iShares Russell 2000 ETF1.97M1.76%
Columbia Funds Series Trust I-Columbia Small Cap Growth Fund1.76M1.58%
SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF1.75M1.57%
Franklin Strategic Series-Franklin Biotechnology Discovery Fund1.41M1.26%
Fidelity Salem Street Trust-Fidelity Small Cap Index Fund864.55K0.77%
VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund774.01K0.69%
Fidelity Advisor Series VII-Fidelity Advisor Biotechnology Fund677.57K0.61%
iShares Trust-iShares Biotechnology ETF669.09K0.60%

Frequently asked questions

Who is the largest shareholder of Solid Biosciences?

RA Capital Management, L.P. is the largest institutional shareholder of SLDB, owning 10.78% of shares outstanding (12.04M shares) as of its latest 13F filing.

What percentage of Solid Biosciences is owned by institutions?

Institutions own about 106.1% of SLDB shares and 106.8% of the public float.

How much of Solid Biosciences do insiders own?

Insiders, such as officers and directors, own about 0.66% of SLDB shares outstanding.

Where does institutional ownership data come from?

Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.

Related